Disease: Transitional cell carcinoma
- A Case of Colon Metastasis after Surgery for Left Renal Pelvis Cancer
- A chromosome-scale fishing cat reference genome for the evaluation of potential germline risk variants
- A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality
- A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing
- A new standard of care for advanced-stage urothelial carcinoma
- Adipose Stromal Cell-Derived Cancer-Associated Fibroblasts Suppress FGFR Inhibitor Efficacy
- Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor with low HER-2 expression
- Arab world's impact on bladder cancer research and opportunities for growth: A bibliometric review study
- Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model
- Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab
- Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma
- Bacillus Calmette-Guérin-induced kidney granulomas
- Bladder Cancer Detected Incidentally by Cystoscopy before Radical Prostatectomy
- Bladder cancer: An Update
- Bowen disease with sebaceous differentiation arising from clonal seborrheic keratosis
- Cardiac and Intramuscular Metastases Following Nephroureterectomy for Metachronous Urothelial Carcinoma
- Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit
- Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study
- Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma
- Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial
- Clinical implications of single cell sequencing for bladder cancer
- Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder
- Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
- Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study
- Clinicopathological and molecular characteristics of esophageal carcinoma with ductal differentiation: analysis of 17 cases
- Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockade
- Comparison of European and American Guidelines for Upper Tract Urothelial Carcinoma: How Are They different?
- Comparison of intravesical chemotherapy regimens after radical nephroureterectomy for upper tract urothelial carcinoma and analysis of risk factors for postoperative recurrence
- Comparison of Oncological Outcomes between Transperitoneal and Retroperitoneal Approaches in Laparoscopic Nephroureterectomies for Upper Tract Urothelial Carcinoma
- Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan
- Complications of intravesical BCG therapy
- Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective
- CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series
- Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients
- Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study
- Development and validation of a clinical and ultrasound features-based nomogram for preoperative differentiation of renal urothelial carcinoma and central renal cell carcinoma
- Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades
- Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma
- Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma
- Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis
- Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases
- Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis
- Endothelial cell proliferation and vascular patterns in urothelial carcinoma
- Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer
- Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
- Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers
- Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study
- Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy
- Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade
- FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape
- FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation Sequencing
- Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
- Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
- Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
- Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer
- Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data
- Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer
- Letter to the editor for the article "Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma"
- Letter to the editor for the article "Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma"
- Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma"
- Lower and upper urinary tract urothelial carcinoma in crossed fused ectopic kidney
- Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma
- Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
- Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential
- On relevant features for the recurrence prediction of urothelial carcinoma of the bladder
- Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma
- Outcome Analysis of a Series of Mixed-Grade, Non-muscle Invasive, Papillary Carcinomas of the Bladder
- PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
- Phase II Study of Erdafitinib in Patients With Tumors With <em>FGFR</em> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1
- Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2
- Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score
- Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma
- Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma
- Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature
- Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma
- Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urography
- Radiation toxicity grading after chemoradiotherapy of canine urinary tract carcinomas: Comparing VRTOG to VRTOG_v2.0
- Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer
- Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan
- Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma," by Urabe, Fumihik et al
- Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy
- Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments
- Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma
- Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy
- Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
- Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and challenging feature. A case report
- Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma
- Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort
- The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature
- The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma- A review of the literature
- The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis
- The Evolution of Upper Tract Urothelial Carcinoma Management in Kidney Recipients
- The role of histological subtype and chemotherapy on prognosis of ureteral cancer
- TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma
- Unusual Urothelial Tumors and Refractory Uremia Due to Balkan Endemic Nephropathy: A Case Report
- Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study
- Urothelial Carcinoma: Epidemiology and Imaging-Based Review
- Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy
- Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature